OAD

DRUG2 trials

Sponsors

Taipei Veterans General Hospital, Taiwan, Boehringer Ingelheim

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes

Unknown Phase

Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control

CompletedNCT00506194

Taipei Veterans General Hospital, TaiwanType 2 Diabetes

Start: 2005-10-31End: 2011-12-31Target: 60Updated: 2013-10-01

Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus

CompletedNCT01650259

Boehringer IngelheimDiabetes Mellitus, Type 2

Start: 2012-07-23End: 2017-09-14Updated: 2019-09-18

Related Papers

Long-term safety and effectiveness of linagliptin by baseline body mass index in Japanese patients with type 2 diabetes: a 3-year post-marketing surveillance study

Expert Opinion on Drug Safety2022-04-14

Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study.

2020-01-132 citations

Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study

Diabetes Therapy2019-11-1110 citations